The firms had launched generic versions of Boehringer's patent-protected drug Linagliptin, which is marketed under the brand name Trajenta
The Mumbai-based company said it is committed to providing affordable treatment options to healthcare providers and patients
Chairman Y K Hamied and Vice Chairman MK Hamied, who are non-executive directors and promoters, have sold 2,01,69,756 shares on Tuesday
The company had posted a consolidated net profit of Rs 265.47 crore in the corresponding period last fiscal, Ipca Laboratories said in a regulatory filing
The Hyderabad-based company had reported a net profit of Rs 63.4 crore in the October-December period of previous fiscal
The test-flight was focused on delivering critical lifesaving medicines to hospitals in under 10 minutes, maintaining the cold chain and all the norms
New entrants in the largely unorganised Indian pharmaceuticals market are trying out innovative ways to tap a vast market that lies in hinterland
Plans to raise Rs 1,500-1,600 cr; This is the second pharmacy chain to file for IPO after Hyderabad-based MedPlus, which filed its DRHP with Sebi in August
Also, Lupin is looking for franchise partners with an investment of Rs 2-5 lakh without any security deposit
Lupin's portfolio and pipeline addresses 70 per cent of the entire market
The examination will be conducted online and the notification for EAPCET will be released on June 24.
The medical devices makers' industry body, too, has written to the NITI Aayog seeking vaccination on priority.
Drug firm Gland Pharma on Monday reported a 34 per cent rise in its consolidated net profit to Rs 260.4 crore for the fourth quarter ended March 2021, on account of robust sales
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ Ahmedabad
Chemistry For Better Living
Core hospital segment too is looking up on the back of rise in occupancies, footfalls
Standalone revenues of the healthcare services division decreased by 18% to Rs 1,062.6 crore in Q2FY21.
Shanghai-listed Laobaixing, formally known as LBX Pharmacy Chain Joint Stock Company and which boasts Tencent Holdings Ltd as a backer
Target company makes and supplies active pharmaeutical ingredients in the central nervous system space to some of the world's largest drug makers
Dingg, which is awarded a grant under the government's CAWACH initiative, is growing massively as store-owners take measures to prevent over-crowding